Literature DB >> 28911167

In Utero Exposure to a High-Fat Diet Programs Hepatic Hypermethylation and Gene Dysregulation and Development of Metabolic Syndrome in Male Mice.

Yoshinori Seki1, Masako Suzuki2, Xingyi Guo3, Alan Scott Glenn1, Patricia M Vuguin1, Ariana Fiallo1, Quan Du1, Yi-An Ko4, Yiting Yu5, Katalin Susztak4, Deyou Zheng2,3,6, John M Greally2,7,8, Ellen B Katz1, Maureen J Charron1,8,9.   

Abstract

Exposure to a high-fat (HF) diet in utero is associated with increased incidence of cardiovascular disease, diabetes, and metabolic syndrome later in life. However, the molecular basis of this enhanced susceptibility for metabolic disease is poorly understood. Gene expression microarray and genome-wide DNA methylation analyses of mouse liver revealed that exposure to a maternal HF milieu activated genes of immune response, inflammation, and hepatic dysfunction. DNA methylation analysis revealed 3360 differentially methylated loci, most of which (76%) were hypermethylated and distributed preferentially to hotspots on chromosomes 4 [atherosclerosis susceptibility quantitative trait loci (QTLs) 1] and 18 (insulin-dependent susceptibility QTLs 21). Interestingly, we found six differentially methylated genes within these hotspot QTLs associated with metabolic disease that maintain altered gene expression into adulthood (Arhgef19, Epha2, Zbtb17/Miz-1, Camta1 downregulated; and Ccdc11 and Txnl4a upregulated). Most of the hypermethylated genes in these hotspots are associated with cardiovascular system development and function. There were 140 differentially methylated genes that showed a 1.5-fold increase or decrease in messenger RNA levels. Many of these genes play a role in cell signaling pathways associated with metabolic disease. Of these, metalloproteinase 9, whose dysregulation plays a key role in diabetes, obesity, and cardiovascular disease, was upregulated 1.75-fold and hypermethylated in the gene body. In summary, exposure to a maternal HF diet causes DNA hypermethylation, which is associated with long-term gene expression changes in the liver of exposed offspring, potentially contributing to programmed development of metabolic disease later in life.
Copyright © 2017 Endocrine Society.

Entities:  

Mesh:

Year:  2017        PMID: 28911167      PMCID: PMC5659663          DOI: 10.1210/en.2017-00334

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  47 in total

1.  Cell specific patterns of methylation in the human placenta.

Authors:  Ariadna Grigoriu; Jose Carlos Ferreira; Sanaa Choufani; Dora Baczyk; John Kingdom; Rosanna Weksberg
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

2.  A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry.

Authors:  Reid F Thompson; Masako Suzuki; Kevin W Lau; John M Greally
Journal:  Bioinformatics       Date:  2009-06-26       Impact factor: 6.937

3.  New target regions for human hypertension via comparative genomics.

Authors:  M Stoll; A E Kwitek-Black; A W Cowley; E L Harris; S B Harrap; J E Krieger; M P Printz; A P Provoost; J Sassard; H J Jacob
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

4.  Tissue-specific expression and regulation of sexually dimorphic genes in mice.

Authors:  Xia Yang; Eric E Schadt; Susanna Wang; Hui Wang; Arthur P Arnold; Leslie Ingram-Drake; Thomas A Drake; Aldons J Lusis
Journal:  Genome Res       Date:  2006-07-06       Impact factor: 9.043

5.  Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.

Authors:  Mathias Ehrich; Matthew R Nelson; Patrick Stanssens; Marc Zabeau; Triantafillos Liloglou; George Xinarianos; Charles R Cantor; John K Field; Dirk van den Boom
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-21       Impact factor: 11.205

6.  A map of the cis-regulatory sequences in the mouse genome.

Authors:  Yin Shen; Feng Yue; David F McCleary; Zhen Ye; Lee Edsall; Samantha Kuan; Ulrich Wagner; Jesse Dixon; Leonard Lee; Victor V Lobanenkov; Bing Ren
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

7.  Characterizing DNA methyltransferases with an ultrasensitive luciferase-linked continuous assay.

Authors:  Ivan Hemeon; Jemy A Gutierrez; Meng-Chiao Ho; Vern L Schramm
Journal:  Anal Chem       Date:  2011-05-16       Impact factor: 6.986

Review 8.  Minireview: Epigenetic programming of diabetes and obesity: animal models.

Authors:  Yoshinori Seki; Lyda Williams; Patricia M Vuguin; Maureen J Charron
Journal:  Endocrinology       Date:  2012-01-17       Impact factor: 4.736

9.  TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.

Authors:  Sandra Gardam; Frederic Sierro; Antony Basten; Fabienne Mackay; Robert Brink
Journal:  Immunity       Date:  2008-02-28       Impact factor: 31.745

Review 10.  DNA methyltransferases: a novel target for prevention and therapy.

Authors:  Dharmalingam Subramaniam; Ravi Thombre; Animesh Dhar; Shrikant Anant
Journal:  Front Oncol       Date:  2014-05-01       Impact factor: 6.244

View more
  16 in total

1.  Antioxidant Effects of N-Acetylcysteine Prevent Programmed Metabolic Disease in Mice.

Authors:  Maureen J Charron; Lyda Williams; Yoshinori Seki; Xiu Quan Du; Bhagirath Chaurasia; Alan Saghatelian; Scott A Summers; Ellen B Katz; Patricia M Vuguin; Sandra E Reznik
Journal:  Diabetes       Date:  2020-05-22       Impact factor: 9.461

2.  Maternal high fat diet and its consequence on the gut microbiome: A rat model.

Authors:  Phyllis E Mann; Kevin Huynh; Giovanni Widmer
Journal:  Gut Microbes       Date:  2017-11-28

3.  Transgenerational impact of maternal obesogenic diet on offspring bile acid homeostasis and nonalcoholic fatty liver disease.

Authors:  Michael D Thompson; Alaina Derse; Jeremie LA Ferey; Michaela Reid; Yan Xie; Miranda Christ; Deyali Chatterjee; Chau Nguyen; Natalia Harasymowicz; Farshid Guilak; Kelle H Moley; Nicholas Oliver Davidson
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-12       Impact factor: 4.310

Review 4.  Cytosine Methylation Studies in Patients with Diabetic Kidney Disease.

Authors:  Tamas Aranyi; Katalin Susztak
Journal:  Curr Diab Rep       Date:  2019-08-30       Impact factor: 4.810

Review 5.  Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease.

Authors:  Peter R Baker; Jacob E Friedman
Journal:  J Clin Invest       Date:  2018-08-31       Impact factor: 14.808

6.  High-fat diet affects pregestational adiposity and glucose tolerance perturbing gestational placental macronutrient transporters culminating in an obese offspring in wild-type and glucose transporter isoform 3 heterozygous null mice.

Authors:  Amit Ganguly; Sherin U Devaskar
Journal:  J Nutr Biochem       Date:  2018-09-13       Impact factor: 6.048

7.  The protective effect of neonatal oral administration of oleanolic acid against the subsequent development of fructose-induced metabolic dysfunction in male and female rats.

Authors:  Trevor T Nyakudya; Emmanuel Mukwevho; Kennedy H Erlwanger
Journal:  Nutr Metab (Lond)       Date:  2018-11-20       Impact factor: 4.169

Review 8.  Epigenetics of Hepatic Insulin Resistance.

Authors:  Hannah Maude; Claudia Sanchez-Cabanillas; Inês Cebola
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-11       Impact factor: 5.555

Review 9.  Developmental Programming of Obesity and Diabetes in Mouse, Monkey, and Man in 2018: Where Are We Headed?

Authors:  Jacob E Friedman
Journal:  Diabetes       Date:  2018-11       Impact factor: 9.461

10.  Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates.

Authors:  Stephanie R Wesolowski; Christopher M Mulligan; Rachel C Janssen; Peter R Baker; Bryan C Bergman; Angelo D'Alessandro; Travis Nemkov; Kenneth N Maclean; Hua Jiang; Tyler A Dean; Diana L Takahashi; Paul Kievit; Carrie E McCurdy; Kjersti M Aagaard; Jacob E Friedman
Journal:  Mol Metab       Date:  2018-09-28       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.